Mirza Yusuf H, Oussedik Sam
Trauma Fellow, Department of Trauma and Orthopaedics, Royal Gwent Hospital, Newport, NP20 2UB.
Consultant Trauma and Orthopaedic Surgeon, Department of Department of Trauma and Orthopaedics, University College Hospital, London.
Br J Hosp Med (Lond). 2017 Jul 2;78(7):372-377. doi: 10.12968/hmed.2017.78.7.372.
Articular cartilage is a specialized tissue with a high prevalence of injuries. The complex architecture of articular cartilage means that injuries are difficult to treat. The sequelae of such injuries include post-traumatic osteoarthritis. Current treatments include microfracture, microdrilling, osteochondral transplantation and matrix autologous chondral implantation. However, current surgical therapies have a number of disadvantages. Mesenchymal stem cells have been suggested as a potential alternative therapy, with a theoretical ability to regenerate articular cartilage. Research, although positive, is mainly limited to case series, in which the follow up is short to medium term. Stem cells may hold the answer to the age-old problem of articular cartilage injury but more robust evidence is required.
关节软骨是一种损伤发生率很高的特殊组织。关节软骨复杂的结构意味着损伤难以治疗。此类损伤的后遗症包括创伤后骨关节炎。目前的治疗方法包括微骨折、微钻孔、骨软骨移植和自体软骨细胞基质植入。然而,目前的手术治疗存在一些缺点。间充质干细胞已被提议作为一种潜在的替代疗法,理论上具有再生关节软骨的能力。尽管研究结果是积极的,但主要限于病例系列,随访时间为短期至中期。干细胞可能是解决关节软骨损伤这一古老问题的答案,但需要更有力的证据。